Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy

Benzer Materyaller

• Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin
  Yazar:: Kahwaji, Joseph, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Desensitization Therapy with Intravenous Gammaglobulin (IVIG): Applications in Solid Organ Transplantation
  Yazar:: Jordan, Stanley C, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
  Yazar:: A. I. Sushkov, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-06-01)
• Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
  Yazar:: Kakuta, Yoichi, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Infectious Complications in Living-Donor Kidney Transplant Recipients Undergoing Multi-Modal Desensitization
  Yazar:: Turza, Kristin C., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)